206 related articles for article (PubMed ID: 37148296)
41. Multiparametric Imaging of Tumor Hypoxia and Perfusion with
Grkovski M; Schöder H; Lee NY; Carlin SD; Beattie BJ; Riaz N; Leeman JE; O'Donoghue JA; Humm JL
J Nucl Med; 2017 Jul; 58(7):1072-1080. PubMed ID: 28183993
[TBL] [Abstract][Full Text] [Related]
42. The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Wobb J; Krueger SA; Kane JL; Galoforo S; Grills IS; Wilson GD; Marples B
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):820-8. PubMed ID: 26104936
[TBL] [Abstract][Full Text] [Related]
43. Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.
Teng F; Aryal M; Lee J; Lee C; Shen X; Hawkins PG; Mierzwa M; Eisbruch A; Cao Y
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):969-977. PubMed ID: 29428251
[TBL] [Abstract][Full Text] [Related]
44. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
[TBL] [Abstract][Full Text] [Related]
45. Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Zips D; Thorwarth D
Acta Oncol; 2013 Oct; 52(7):1308-13. PubMed ID: 23984808
[TBL] [Abstract][Full Text] [Related]
46. Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.
Georg P; Andrzejewski P; Baltzer P; Daniel M; Wadsak W; Mitterhauser M; Sturdza A; Majercakova K; Karanikas G; Pötter R; Hacker M; Helbich T; Georg D; Pinker K
Mol Imaging Biol; 2018 Feb; 20(1):160-169. PubMed ID: 28540524
[TBL] [Abstract][Full Text] [Related]
47. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
[TBL] [Abstract][Full Text] [Related]
48. Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy.
Socarrás Fernández JA; Mönnich D; Leibfarth S; Welz S; Zwanenburg A; Leger S; Löck S; Pfannenberg C; La Fougère C; Reischl G; Baumann M; Zips D; Thorwarth D
Phys Imaging Radiat Oncol; 2020 Jul; 15():52-59. PubMed ID: 33043157
[TBL] [Abstract][Full Text] [Related]
49. [18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.
Cheney MD; Chen YL; Lim R; Winrich BK; Grosu AL; Trofimov AV; Depauw N; Shih HA; Schwab JH; Hornicek FJ; DeLaney TF
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1030-6. PubMed ID: 25539367
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.
Eschmann SM; Paulsen F; Bedeshem C; Machulla HJ; Hehr T; Bamberg M; Bares R
Radiother Oncol; 2007 Jun; 83(3):406-10. PubMed ID: 17543402
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of Optimal Post-Injection Timing of Hypoxic Imaging with
Kawamura M; Yoshimura M; Shimizu Y; Sano K; Ishimori T; Nakamoto Y; Mizowaki T; Hiraoka M
Mol Imaging Biol; 2021 Aug; 23(4):597-603. PubMed ID: 33475945
[TBL] [Abstract][Full Text] [Related]
52. Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.
Arvold ND; Heidari P; Kunawudhi A; Sequist LV; Mahmood U
Technol Cancer Res Treat; 2016 Apr; 15(2):234-42. PubMed ID: 25759424
[TBL] [Abstract][Full Text] [Related]
53. [Individualised radiotherapy on the basis of functional imaging with FMISO PET].
Thorwarth D; Alber M
Z Med Phys; 2008; 18(1):43-50. PubMed ID: 18524387
[TBL] [Abstract][Full Text] [Related]
54. Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients.
Winter RM; Leibfarth S; Schmidt H; Zwirner K; Mönnich D; Welz S; Schwenzer NF; la Fougère C; Nikolaou K; Gatidis S; Zips D; Thorwarth D
Radiother Oncol; 2018 Sep; 128(3):485-491. PubMed ID: 29747873
[TBL] [Abstract][Full Text] [Related]
55. Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.
Preibisch C; Shi K; Kluge A; Lukas M; Wiestler B; Göttler J; Gempt J; Ringel F; Al Jaberi M; Schlegel J; Meyer B; Zimmer C; Pyka T; Förster S
NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28805936
[TBL] [Abstract][Full Text] [Related]
56. Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?
Abolmaali N; Haase R; Koch A; Zips D; Steinbach J; Baumann M; Kotzerke J; Zöphel K
Nuklearmedizin; 2011; 50(1):22-7. PubMed ID: 21165537
[TBL] [Abstract][Full Text] [Related]
57. Tumoral hypoxia in osteosarcoma in rats: preliminary study of blood oxygenation level-dependent functional MRI and 18F-misonidazole PET/CT with diffusion-weighted MRI correlation.
Dallaudiere B; Hummel V; Hess A; Lincot J; Preux PM; Maubon A; Monteil J
AJR Am J Roentgenol; 2013 Feb; 200(2):W187-92. PubMed ID: 23345383
[TBL] [Abstract][Full Text] [Related]
58. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
59. Impact of hybrid PET/MR technology on multiparametric imaging and treatment response assessment of cervix cancer.
Daniel M; Andrzejewski P; Sturdza A; Majercakova K; Baltzer P; Pinker K; Wadsak W; Mitterhauser M; Pötter R; Georg P; Helbich T; Georg D
Radiother Oncol; 2017 Dec; 125(3):420-425. PubMed ID: 29153465
[TBL] [Abstract][Full Text] [Related]
60. Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
Boeke S; Thorwarth D; Mönnich D; Pfannenberg C; Reischl G; La Fougère C; Nikolaou K; Mauz PS; Paulsen F; Zips D; Welz S
Acta Oncol; 2017 Nov; 56(11):1571-1576. PubMed ID: 28891398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
